Aberrant hormone production from ovarian neoplasms: Strategies for diagnosis and therapy

Steven D. Leach, Annette I. LaMorte, Lawrence D. True, Stuart D. Flynn, Peter E. Schwartz, C. Elton Cahow, Barbara K. Kinder

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Syndromes involving peptide or nonsex steroid hormone secretion due to aberrantly located tumors are rare. We report a collected series of 16 patients with ectopic hormone production from ovarian neoplasms, including 3 patients recently encountered at our institution as well as 13 additional cases identified in the recent literature. These tumors included 2 insulin-producing ovarian carcinoids, 1 ACTH-producing pituitary adenoma within a benign ovarian cystic teratoma, 2 cortisol-producing ovarian neoplasms, 8 gastrin-producing ovarian cystadenomata or cystadenocarcinomata, and 3 thyroxine-producing ovarian strumal carcinoids. All patients presented with syndromes of hormone excess. Only 62% of all tumors were localized preoperatively. Following ovarian resection, 87% of patients remained disease-free with a median follow-up period of 1.5 years. In addition to ovariectomy, 8 additional unnecessary ablative procedures were performed in 7 patients. These included distal pancreatectomy, pancreaticoduodenectomy, adrenalectomy, total gastrectomy, selective vagotomy, and subtotal thyroidectomy. Failure to localize the ovarian neoplasm preoperatively was associated with a significantly higher risk of subsequent unnecessary ablative procedures. Because of the potential for the ovary to act as a source of aberrant hormone secretion, we recommend complete preoperative evaluation of the pelvis in female patients presenting with nonlocalizable endocrine tumors.

Original languageEnglish (US)
Pages (from-to)335-340
Number of pages6
JournalWorld journal of surgery
Volume14
Issue number3
DOIs
StatePublished - May 1 1990

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Aberrant hormone production from ovarian neoplasms: Strategies for diagnosis and therapy'. Together they form a unique fingerprint.

Cite this